Top Tweets for #SLAMF7
Calum Bain adding insights on Dynamics and behavior of mucosal macrophages in health and disease #SLAMF7
Wow, congratulations to this personal achievement! 👏
@H_Einsele is partner of our @CARAMBA_project, a #H2020 research project evaluating safety and efficacy of #SLAMF7 specific #CARTcells treating #MultipleMyeloma patients.
We congratulate @CARAMBA_project Project Coordinator Prof. Michael Hudecek who was awared the Schelling-Preis for his excellent research on #innovative #cancerresearch and #CART cells! 🥳👏
Evaluating safety & efficacy of #SLAMF7 #CARTcells treating in #MultipleMyeloma patients.
Glückwunsch an alle PreisträgerInnen und vor allem an Michael Hudecek vom UKW zum wichtigsten Wissenschaftspreis der @badw_muenchen, den Schelling-Preis.
https://t.co/g2H4PupNBH
Bild: Akademiepräsident Höllmann (links) und Hudecek © BAdW/Stefan Obermeier
SLAMF7 selectively favors degranulation to promote cytotoxicity in human NK cells
Gutierrez-Guerrero, Mancilla-Herrera, Maravillas-Montero, Martinez-Duncker, Veillette, E. Cruz-Munoz @uaemorelos
#SLAMF7 #NKcells #cytotoxicity
https://t.co/ntEVZcJUYC
New target in #SLE 🧐
#CD38 and #SLAMF7 (KA Hogan et al and M Humbel et al) new therapy horizons?🦾🤞🏻 @eular_org @EMEUNET @Lupusreference @SIRyoung_IT @CollegioCrei
In the @CARAMBA_project phase I/IIa clinical trial, the new intervention is a #CART cell treatment focused on a specific protein called #SLAMF7. #CARAMBA will recruit up to 38 #myeloma patients and will be available at specific sites in Germany, Spain, France and Italy.
.@EU_H2020 @CARAMBA_project information sheet is now available in 5 languages! This publication discusses potential #CART side effects, considerations for #myeloma patients, and the main goals of the CARAMBA clinical trial.
https://t.co/RA7emQJuOn
🔬New technologies for prevention, treatment & care are key to meet the goals of the #EUCancerPlan.
In our @CARAMBA_project 10 partners of 6 🇪🇺 countries are collaborating to transfer the #CART “Breakthrough Therapy” from bench to bedside.
#MultipleMyeloma #SLAMF7 #CARTcells
... Nothing to add! Thanks for hosting this European #CARTcell Meeting of which ARTTIC managed projects @CARAMBA_project and @EURECART_EU could be a part! Their mission? -> Finding new treatment methods for #MultipleMyeloma, #lymphoma and #acutelymphoblastic leukemia. #SLAMF7
#CART21 has come to an end. Thank you @TheEBMT and @EHA_Hematology for hosting such an inspirational meeting! It was a pleasure to attend and being part of it all. Looking forward to continue the collaboration.
See you next year👋. Stay safe.
Three days left to register for the 3rd European CAR T-cell Meeting on Thursday 4 – Saturday 6 February. Registration is possible until 31.01.: https://t.co/ia6vGje0tE.
#CART21 #SLAMF7 #CARTcells #MultipleMyeloma
.@CARAMBA_project project partners will be joining the 3rd European #CARTcell Meeting organised by @TheEBMT & @EHA_Hematology on 4-6 Feb. The CARAMBA team is evaluating safety and efficacy of #SLAMF7 specific #CARTcells treating #MultipleMyeloma patients.
https://t.co/o8w9s12fjf
Prof. Einsele, partner of the #ARTTICInnovation managed @CARAMBA_project talks about chimeric antigen receptor (CAR) T-cell therapy in #MultipleMyeloma during #EBMT20Virtual. The multidisciplinary consortium evaluates the safety & efficacy of #SLAMF7 specific #CARTcells.
CONGRESS | #EBMT20Virtual | 👀See Hermann Einsele discuss the new SLAMF7-targeted CAR T-cell therapy with the @MM_Hub #mmsm #MYELOMA https://t.co/YOWewRwAAS @Uni_WUE @H_Einsele
Watch the video interview with Michael Hudecek, coordinator of the #H2020 @CARAMBA_project, and get deeper insights into #SLAMF7 #CARTcell treatment of #MultipleMyeloma patients and the @CARAMBA_project #clinicaltrials:
https://t.co/gUYq4yOdmg
@ARTTIC_RTD @CORDIS_EU @EU_H2020
VIDEO: #MonoclonalAntibodies: are they the future of #MultipleMyeloma treatment? Faith Davies @1MIRT explores their potential: https://t.co/IaUIThozzq @ASCO #ASCO18 #Leusm #MMSM #HemOnc #Leukemia #Myeloma #BCMA #CARTcells #CD38 #ClinicalTrials #Immunotherapy #SLAMF7 #ImmunoOnc
The exiting #Horizon2020 @CARAMBA_project kick-off meeting full of discussions on #SLAMF7 #CARTcell and its chances for #MultipleMyeloma. Let's be pioneers!
VIDEO: We spoke to Sattva Neelapu of @MDAndersonNews at #ASH17 about a new CAR T-cell targeting #SLAMF7, which is showing efficacy against #MultipleMyeloma: https://t.co/NpWKPwl1NW @ASH_hematology #hemeonc #MMSM #Myeloma #ImmunoOnc #CART #CARTcell
new Kochenderfer review @BloodJournal on #CARTcells in #myeloma: covers current targets + data from ongoing trials. Most promise for #BCMA and #SLAMF7 but most likely will still need new antigens + figure out best combos with existing meds #immunotherapy
https://t.co/p3OGEHa67M
Tonight, 18ct @rabonour1 discusses
#MAb
#SLAMF7
#CD38, 19
#Checkpoint Inhibitors
#CAR-T
#CAR-BCMA T
#mmsm #myeloma
https://t.co/yGHb6mx1xM
Most Popular Users
Elon Musk 
@elonmusk
240.7M followers
Barack Obama
@barackobama
119.2M followers
Donald J. Trump
@realdonaldtrump
111.7M followers
Cristiano Ronaldo
@cristiano
111M followers
Narendra Modi
@narendramodi
107M followers
Rihanna
@rihanna
97.7M followers
NASA
@nasa
92.2M followers
Justin Bieber
@justinbieber
91M followers
KATY PERRY
@katyperry
87.8M followers
Taylor Swift
@taylorswift13
81.7M followers
Lady Gaga
@ladygaga
73.2M followers
Virat Kohli
@imvkohli
70.2M followers
Kim Kardashian
@kimkardashian
69.9M followers
YouTube
@youtube
68.7M followers
Bill Gates
@billgates
64M followers
Neymar Jr
@neymarjr
63M followers
The Ellen Show
@theellenshow
62.4M followers
CNN
@cnn
61.9M followers
Selena Gomez
@selenagomez
60.9M followers
X
@x
60.8M followers